Cyclerion Therapeutics's market cap is currently ―. The company's EPS TTM is $-9.074; its P/E ratio is -0.32; Cyclerion Therapeutics is scheduled to report earnings on May 1, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	$ 608.00K
Gross Profit	-	-	-	-	$ 608.00K
EBIT	$ 4.45M	$ -5.91M	$ -4.18M	$ -6.95M	$ -7.35M
EBITDA	$ 4.45M	$ -5.91M	$ -4.18M	$ -6.95M	$ -7.37M
Net Income Common Stockholders	$ -1.69M	$ 7.57M	$ -4.18M	$ -6.95M	$ -7.22M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 7.57M	$ 9.11M	$ 5.64M	$ 7.17M	$ 13.38M
Total Assets	$ 13.37M	$ 15.21M	$ 10.10M	$ 11.46M	$ 18.08M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -7.57M	$ -9.11M	$ -5.64M	$ -7.17M	$ -13.38M
Total Liabilities	$ 2.09M	$ 2.34M	$ 4.95M	$ 7.53M	$ 7.63M
Stockholders Equity	$ 11.29M	$ 12.87M	$ 5.15M	$ 3.92M	$ 10.45M
Cash Flow	-
Free Cash Flow	$ -1.54M	$ -6.93M	$ -6.55M	$ -6.21M	$ -7.04M
Operating Cash Flow	$ -1.54M	$ -6.93M	$ -6.55M	$ -6.21M	$ -7.04M
Investing Cash Flow	-	$ 10.40M	-	-	-
Financing Cash Flow	-	-	$ 5.02M	-	$ 12.00K

Currency in USD

Cyclerion Therapeutics Earnings and Revenue History

Income Statement >

Cyclerion Therapeutics Debt to Assets

Balance Sheet >

Cyclerion Therapeutics Cash Flow

Cash Flow >

Cyclerion Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing